Har-Even M, Rubovitch V, Ratliff WA, Richmond-Hacham B, Citron BA, Pick CG
Doctronic offers AI-powered consultations that can synthesize the latest medical knowledge to provide personalized care
Abstract: Pastore, A., Federici, G., Bertini, E., & Piemonte, F
Gastrointestinal side effects observed under cotadutide effects are similar in quality but more severe than those under GLP-1RA treatment ( Animal data on a GLP-1/GIP/glucagon triple agonist show strong effects on body weight reduction, and glucose- and lipid normalization in rodents
The Medicare GLP-1 Bridge Program lets eligible Medicare Part D beneficiaries get Wegovy, Zepbound, or Foundayo for a $50 per month medication copay from July 1, 2026 through December 31, 2027